I really don't have any definitive answer but I'm hearing from some other investors that it is pretty imminent. It should not have taken them a lot of time to achieve what they are doing, given the massive mAB library they have and the use of AI to isolate the neutralizing anti bodies.
I am sure they are doing their due diligence before releasing the results rather than give prelim data and fail like Moderna and Sorrento. Hopefully, this keeps going up and when they release the research data we will be in the $ Billion market cap range.
News 
Market Data 
Discover 
